---
figid: PMC2517145__nihms54908f1
figlink: /pmc/articles/PMC2517145/figure/F1/
number: Figure 1
caption: Activated receptor tyrosine kinases (RTKs) signal through scaffolding adaptors
  (e.g. IRS-1) that activate PI-3kinase. Pten suppresses the activation of Akt. Deletion
  of Pten leads to the hyperactivation Akt, loss of FoxO function, and activation
  of the mTorc1 and mTorc2 complexes. Important target genes of FoxO include regulators
  of cell death (e.g. Bim-1 and Fas-L), cell cycle progression (e.g. p21Cip1 and p27Kip1),
  and ROS detoxification (e.g. catalase and MnSOD). There are multiple pathways downstream
  of activated mTorc1, including S6 kinase (which regulates protein synthesis and
  ribosome biogenesis) and 4E-BP1 (which regulates cap-dependent translation). Rapamycin
  treatment reduces the activation of S6K, reduces the inhibition of 4E-BP and rescues
  the function of Pten-deficient HSCs. Although Akt activation leads to mTorc1 activation,
  mTorc1 activation can reduce Akt activation by a negative feedback mechanism involving
  S6K. Rapamycin treatment can disrupt this negative feedback mechanism and therefore
  increase Akt signaling, which affects the many effectors that lie downstream of
  Akt. Downstream targets of mTorc2 include kinases such as PKCα Rho, Rac, and Akt.
  Prolonged rapamycin treatment has been demonstrated to also inhibit assembly of
  the mTorc2 complex by sequestering mTor, leading to decreased Akt activation. This
  finding raises the possibility that rapamycin treatment may also restore FoxO function
  in Pten-deficient HSCs by inhibiting mTorc2. Abbreviations (RTKs, receptor tyrosine
  kinases; IRS-1, insulin receptor substrate-1; PI-3K, phosphatidylinositol-3-OH kinase;
  Fas-L, Fas ligand; MnSOD, manganese superoxide dismutase; mTorc1, mTor complex 1;
  mTorc2, mTor complex 2; 4E-BP1, eukaryotic translation initiation factor 4E binding
  protein 1; eIF4E, eukaryotic translation initiation factor 4E; S6K, S6 kinase; PKCα,
  protein kinase C alpha)
pmcid: PMC2517145
papertitle: 'The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating
  cells: a mechanistic difference between normal and cancer stem cells.'
reftext: Ömer H. Yilmaz, et al. Blood Cells Mol Dis. ;41(1):73-76.
pmc_ranked_result_index: '39334'
pathway_score: 0.9314286
filename: nihms54908f1.jpg
figtitle: 'PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating
  cells: a mechanistic difference between normal and cancer stem cells'
year: ''
organisms: Homo sapiens
ndex: 233fb492-deac-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2517145__nihms54908f1.html
  '@type': Dataset
  description: Activated receptor tyrosine kinases (RTKs) signal through scaffolding
    adaptors (e.g. IRS-1) that activate PI-3kinase. Pten suppresses the activation
    of Akt. Deletion of Pten leads to the hyperactivation Akt, loss of FoxO function,
    and activation of the mTorc1 and mTorc2 complexes. Important target genes of FoxO
    include regulators of cell death (e.g. Bim-1 and Fas-L), cell cycle progression
    (e.g. p21Cip1 and p27Kip1), and ROS detoxification (e.g. catalase and MnSOD).
    There are multiple pathways downstream of activated mTorc1, including S6 kinase
    (which regulates protein synthesis and ribosome biogenesis) and 4E-BP1 (which
    regulates cap-dependent translation). Rapamycin treatment reduces the activation
    of S6K, reduces the inhibition of 4E-BP and rescues the function of Pten-deficient
    HSCs. Although Akt activation leads to mTorc1 activation, mTorc1 activation can
    reduce Akt activation by a negative feedback mechanism involving S6K. Rapamycin
    treatment can disrupt this negative feedback mechanism and therefore increase
    Akt signaling, which affects the many effectors that lie downstream of Akt. Downstream
    targets of mTorc2 include kinases such as PKCα Rho, Rac, and Akt. Prolonged rapamycin
    treatment has been demonstrated to also inhibit assembly of the mTorc2 complex
    by sequestering mTor, leading to decreased Akt activation. This finding raises
    the possibility that rapamycin treatment may also restore FoxO function in Pten-deficient
    HSCs by inhibiting mTorc2. Abbreviations (RTKs, receptor tyrosine kinases; IRS-1,
    insulin receptor substrate-1; PI-3K, phosphatidylinositol-3-OH kinase; Fas-L,
    Fas ligand; MnSOD, manganese superoxide dismutase; mTorc1, mTor complex 1; mTorc2,
    mTor complex 2; 4E-BP1, eukaryotic translation initiation factor 4E binding protein
    1; eIF4E, eukaryotic translation initiation factor 4E; S6K, S6 kinase; PKCα, protein
    kinase C alpha)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXO6
  - RICTOR
  - FASLG
  - RHOD
  - FOXO1
  - CCND1
  - MTOR
  - PIK3R5
  - MLST8
  - RAC1
  - AKT3
  - EIF4EBP1
  - PIK3CG
  - PTEN
  - MAPKAP1
  - RHOG
  - RAC2
  - PIK3R3
  - AKT2
  - IRS1
  - PIK3R6
  - FOXO3
  - PRKCA
  - AKT1
  - PIK3CD
  - RAC3
  - FOXO4
  - RPTOR
  - PIK3CA
  - PIK3CB
  - PIK3R4
  - CDKN1B
  - Rapamycin
  - Cancer
genes:
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: mTorc2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: Fas-L
  symbol: FasL
  source: hgnc_alias_symbol
  hgnc_symbol: FASLG
  entrez: '356'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: (CyclinD1)
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: mTorc1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: mTorc2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Pten
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: mTorc2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: PKCA
  symbol: PKCA
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: mTorc2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: mTorc1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: p27Kip1
  symbol: P27KIP1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1B
  entrez: '1027'
chemicals:
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
